University of SaskatchewanHARVEST
  • Login
  • Submit Your Work
  • About
    • About HARVEST
    • Guidelines
    • Browse
      • All of HARVEST
      • Communities & Collections
      • By Issue Date
      • Authors
      • Titles
      • Subjects
      • This Collection
      • By Issue Date
      • Authors
      • Titles
      • Subjects
    • My Account
      • Login
      JavaScript is disabled for your browser. Some features of this site may not work without it.
      View Item 
      • HARVEST
      • Electronic Theses and Dissertations
      • Graduate Theses and Dissertations
      • View Item
      • HARVEST
      • Electronic Theses and Dissertations
      • Graduate Theses and Dissertations
      • View Item

      NOVEL GEMINI SURFACTANT-BASED GENE/DRUG DELIVERY SYSTEMS Potential Applications in Melanoma Therapy

      Thumbnail
      View/Open
      MOHAMMEDSAEID-DISSERTATION-2018.pdf (5.649Mb)
      Date
      2018-07-03
      Author
      Mohammed Saeid, Waleed 1984-
      Type
      Thesis
      Degree Level
      Doctoral
      Metadata
      Show full item record
      Abstract
      Melanoma is the most life-threatening form of skin cancer and world-wide statistics show an alarming increase in melanoma incidence and mortality. The aim of my work was to develop and investigate the potential applications of novel drug/gene delivery systems in melanoma therapy. In the first research theme, I explored the application of targeted-gemini surfactant-based gene delivery system in melanoma therapy. Two cancer targeting-peptides (cyclic-RGD and p18-4]) were used to develop melanoma-targeting lipoplexes. Different formulations and transfection techniques were developed and evaluated. Physicochemical and structural properties of peptide-modified lipoplexes were examined. In vitro transfection efficiency and cellular toxicity of the developed lipoplexes were evaluated in human melanoma cell line. Results showed that peptide-modified gemini surfactant-based lipoplexes significantly enhanced the gene transfection activity in A375 cells compared to the non-targeted formulation. In the second research theme, I investigated the application of a novel β-cyclodextrin (βCD) modified gemini surfactant as a potential drug delivery system in melanoma. βCD was chemically attached to a gemini surfactant, producing a novel βCD-conjugate (18:1βCDg) that can self-assemble and form supramolecular nano-complexes. The 18:1βCDg was designed to combine the solubilizing capacity of the βCD and the cell-penetrating ability of the gemini surfactant. Melphalan (Mel) was selected as a model compound for a poorly soluble drug. To assess the solubilizing efficiency of 18:1βCDg, flow-injection analysis tandem mass spectrometric (FIA-MS/MS) methods were developed. FIA-MS/MS results showed a significant increase (over three-fold) in the aqueous solubility of Mel, at 2:1 host-guest molar ratio. Supporting this finding is the fact that One-/two-dimensional Rotating-frame-Overhauser Spectroscopy-Nuclear Magnetic Resonance (1D/2D ROESY-NMR) results indicated the formation of stable 18:1βCDg/Mel inclusion complex at the same molar ratio. In vitro evaluations showed that the optimized 18:1βCDg/Mel complexes significantly improved the chemotherapeutic efficacy of Mel in monolayer, 3D spheroid and in Mel-resistant melanoma cell lines. Subsequently, in vivo acute toxicity in Sprague-Dawley rats and hemolysis assessment were conducted to determine the carrier’s safety profile. It was shown that 18:1βCDg has low hemolytic effect in comparison to native βCD and basic gemini surfactant molecule. Acute toxicity assessments indicated that 18:1βCDg was well-tolerated without significant toxicity.
      Degree
      Doctor of Philosophy (Ph.D.)
      Department
      Pharmacy and Nutrition
      Program
      Pharmacy
      Supervisor
      Badea, Ildiko; El-Aneed, Anas
      Committee
      Dadachova, Ekaterina; Foldvari , Marianna; Bandy, Brian; Tikoo, Suresh
      Copyright Date
      June 2018
      URI
      http://hdl.handle.net/10388/8641
      Subject
      Melanoma, Gemini surfactant, Non-viral gene delivery, Cancer targeting, SAXS, beta-Cyclodextrin, Flow-injection analysis, Melphalan, Toxicity study
      Collections
      • Graduate Theses and Dissertations
      University of Saskatchewan

      University Library

      © University of Saskatchewan
      Contact Us | Disclaimer | Privacy